Pharming Group N.V. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-22: Form 6-K; Period of report 2026-09-22; Description 6-K; Document pharmingannouncespositivep.htm.
- 2026-09-11: Form 6-K; Period of report 2026-09-11; Description 6-K; Document fdaapprovespharmingsjoenja.htm.
- 2026-08-13: Form 6-K; Period of report 2026-08-13; Description 6-K; Document pharmingannouncescommercia.htm.
- 2026-07-30: Form 6-K; Period of report 2026-07-30; Description 6-K; Document a2026hy1pressrelease.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-09-22 | 6-K | 2026-09-22 | 6-K | pharmingannouncespositivep.htm |
| 2026-09-11 | 6-K | 2026-09-11 | 6-K | fdaapprovespharmingsjoenja.htm |
| 2026-08-13 | 6-K | 2026-08-13 | 6-K | pharmingannouncescommercia.htm |
| 2026-07-30 | 6-K | 2026-07-30 | 6-K | a2026hy1pressrelease.htm |
| 2026-06-04 | 6-K | 2026-06-04 | 6-K | pharmingannouncesusfdaacce.htm |
| 2026-05-28 | 6-K | 2026-05-28 | 6-K | pharminggroupannouncesresu.htm |
| 2026-05-22 | 6-K | 2026-05-22 | 6-K | europeancommissiongrantsma.htm |
| 2026-05-07 | 6-K | 2026-05-07 | 6-K | pharminggroupannouncespres.htm |
| 2026-05-07 | 6-K | 2026-05-07 | 6-K | a2026q1pressrelease.htm |
| 2026-04-16 | 6-K | 2026-04-16 | 6-K | pharminggroupannouncesthe2.htm |
| 2026-04-02 | 6-K | 2026-04-02 | 6-K | pharminggroupannouncesthef.htm |
| 2026-03-27 | 6-K | 2026-03-27 | 6-K | pharminggroupreceivesposit.htm |
| 2026-03-24 | 6-K | 2026-03-24 | 6-K | pharminggroupannouncesappr.htm |
| 2026-03-12 | 6-K | 2026-03-12 | 6-K | a2025q4pressrelease.htm |
| 2026-02-03 | 6-K | 2026-02-03 | 6-K | pharminggroupannounces2026.htm |
| 2026-02-02 | 6-K | 2026-02-01 | 6-K | pharminggroupreceivescompl.htm |
| 2026-01-08 | 6-K | 2026-01-08 | 6-K | pharminggroupreportsprelim.htm |